CoChat

Endocrine Consequences of Long-Term Intrathecal Administration of Opioids

Abs, Roger, Verhelst, Johan, Maeyaert, Jan, Van Buyten, Jean-Pierre, Opsomer, Frank, Adriaensen, Hugo, Verlooy, Jan, Van Havenbergh, Tony, Smet, Mike, Van Acker, Kristien · 2000 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Intrathecal administration of opioids is a very efficient tool in the long-term control of intractable nonmalignant pain. However, despite the well known role of opioids in endocrine regulation, few data are available about possible effects on hypothalamic-pituitary function during this treatment. Seventy-three patients (29 men and 44 women; mean age, 49.2 ± 11.7 yr) receiving opioids intrathecally for nonmalignant pain were enrolled for extensive endocrine investigation. At the time of hormonal determination, the mean duration of opioid treatment was 26.6 ± 16.3 months; the mean daily dose of morphine was 4.8 ± 3.2 mg. The control group consisted of 20 patients (11 men and 9 women; mean age, 54.2 ± 14.0 yr) with a comparable pain syndrome but not treated with opioids. Decreased libido or impotency was present in 23 of 24 men receiving opioids. The serum testosterone level was below 9 nmol/L in 25 of 29 men and was significantly lower than that in the control group (P < 0.001). The free androgen index was below normal in 18 of 29 men and was significantly lower than that in the control group (P < 0.001). The serum LH level was less than 2 U/L in 20 of 29 men and was significantly lower than that in the control group (P < 0.001). Serum FSH was comparable in both groups. Decreased libido was present in 22 of 32 women receiving opioids. All 21 premenopausal females developed either amenorrhea or an irregular menstrual cycle, with ovulation in only 1. Serum LH, estradiol, and progesterone levels were lower in the opioid group. In all 18 postmenopausal females significantly decreased serum LH (P < 0.001) and FSH (P = 0.012) levels were found. The 24-h urinary free cortisol excretion was below 20 μg/day in 14 of 71 opioid patients and was significantly lower than that in the control group (P = 0.003). The peak cortisol response to insulin-induced hypoglycemia was below 180 μg/L in 9 of 61 opioid patients and was significantly lower than that in the nonopioid group (P = 0.002). The insulin-like growth factor I sd score was below −2 sd in 12 of 73 opioid patients and was significantly lower than that in the control group (P = 0.002). The peak GH response to hypoglycemia was below 3 μg/L in 9 of 62 subjects and was significantly lower than that in the control group (P = 0.010). Thyroid function tests and PRL levels were considered normal. No metabolic disturbances were recorded, apart from significantly decreased high density lipoprotein cholesterol levels (P = 0.041) and elevated total/high density lipoprotein cholesterol ratio (P = 0.008) in the opioid group compared to the control group. Supplementation with gonadal steroids improved sexual function in most patients. In conclusion, of all patients receiving intrathecal opioids, the large majority of men and all women developed hypogonadotropic hypogonadism, about 15% developed central hypocorticism, and about 15% developed GH deficiency. These findings suggest that further investigations are required to determine the need for systematic endocrine work-up in these patients and the necessity for substitutive therapy.

Overview

Integrity signals

Registry

Crossref · 10.1210/jcem.85.6.6615

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 1

  1. Gijbels, 1998, Neuromodulation of pain. A consensus statement of the European Federation of IASP Chapters (EFIC)., Eur J Pain, 2, 203

Cited by

See all 494

Metadata

Authors
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K.
Affiliations
  • Antwerp University Hospital (BE)
  • Maria Middelares Hospital St. Niklaas (J.-P.V.B.), B-2650 Edegem, Belgium
  • ZNA Middelheim Hospital (BE)
  • Department of Neurosurgery, University Hospital Antwerp (J.V., T.V.H.), B-2650 Edegem, Belgium
  • Department of Endocrinology, University Hospital Antwerp (R.A., K.V.A.), B-2650 Edegem, Belgium
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2000-06-01
Volume
85
Issue
6
Pages
2215-2222
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2135470636
Cited by
491
References
33
Citations by year
2026: 9 · 2025: 7 · 2024: 16 · 2023: 14 · 2022: 22 · 2021: 20 · 2020: 17 · 2019: 23 · 2018: 23 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 20 · 2013: 26 · 2012: 32
FWCI
10.60
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
intrathecal opioids, morphine, hypothalamic-pituitary function, testosterone, free androgen index, luteinizing hormone, follicle-stimulating hormone, amenorrhea, menstrual cycle, sexual desire, erectile dysfunction, urinary free cortisol, insulin-induced hypoglycemia, cortisol response, hypothalamic-pituitary-adrenal axis, chronic non-cancer pain
MeSH terms
Adult, Aged, Aged, 80 and over, Amenorrhea, Analgesics, Opioid, Androgens, Blood Pressure, Hydromorphone, Estradiol, Female, Follicle Stimulating Hormone, Hormones, Humans, Hydrocortisone, Erectile Dysfunction, Injections, Spinal, Luteinizing Hormone, Libido, Male, Middle Aged, Morphine, Pain, Intractable, Intractable Pain, Progesterone, Reference Values, Retrospective Studies, Sex Hormone-Binding Globulin, Premenopause, Postmenopause

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.